SCHEMBL13610290

SCHEMBL13610290

CSSSCc1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2D6 P10635 1/20 0.41
PRMT1 Q99873 1/20 0.41
IDO1 P14902 4/20 0.40
TP53 P04637 1/20 0.40
NOS3 P29474 1/20 0.40
NOS1 P29475 1/20 0.40
NOS2 P35228 1/20 0.40
POLB P06746 1/20 0.39
HSD17B10 Q99714 1/20 0.39
MAOB P27338 1/20 0.39
HSP90AA1 P07900 1/20 0.38
CTSL P07711 1/20 0.38
CTSB P07858 1/20 0.38
CA12 O43570 1/20 0.38
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
CA9 Q16790 1/20 0.38
CALM1 P0DP23 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL576610 0.85 TP53 (0.43) CYP1A2CYP3A4CYP2D6PRMT1IDO1
Dibenzyl Trisulfide SCHEMBL2803113 0.85 IDO1 (0.46) CYP1A2CYP3A4CYP2D6PRMT1IDO1
SCHEMBL1255779 0.85 IDO1 (0.46) CYP1A2CYP3A4CYP2D6PRMT1IDO1
SCHEMBL1255808 0.82 IDO1 (0.44) CYP1A2CYP3A4CYP2D6PRMT1IDO1
SCHEMBL6916072 0.82 IDO1 (0.44) CYP1A2CYP3A4CYP2D6PRMT1IDO1
SCHEMBL11853076 0.82 IDO1 (0.44) CYP1A2CYP3A4CYP2D6PRMT1IDO1
SCHEMBL13610289 0.79 TP53 (0.44) CYP1A2CYP3A4CYP2D6PRMT1IDO1
Dibenzyl Disulfide SCHEMBL16332737 0.79 HSD17B10 (0.52) CYP1A2CYP3A4CYP2D6PRMT1IDO1
Dibenzyl Disulfide SCHEMBL160895 0.79 HSD17B10 (0.52) CYP1A2CYP3A4CYP2D6PRMT1IDO1
Dibenzyl Disulfide SCHEMBL31120434 0.76 HSD17B10 (0.50) CYP1A2CYP3A4CYP2D6PRMT1IDO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108887282-A A kind of composition and preparation method thereof for preventing and treating yellow twig 邓方坤 2018-11-27 CN disclosed
US-8334316-B2 Substituted organosulfur compounds and methods of using thereof ACEA BIOSCIENCES, INC. (US) 2012-12-18 US disclosed
US-7622507-B2 Substituted organosulfur compounds and methods of using thereof ACEA BIOSCIENCES INC. (US) 2009-11-24 US disclosed
US-20090192146-A1 SUBSTITUTED ORGANOSULFUR COMPOUNDS AND METHODS OF USING THEREOF ACEA BIOSCIENCES, INC. (US) 2009-07-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090192146-A1 SUBSTITUTED ORGANOSULFUR COMPOUNDS AND METHODS OF USING THEREOF TST, CTH, CBS CYP1A2 3924/4885CYP3A4 3786/4885CYP2D6 2915/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.